ATRC
AtriCure Inc
60.80$
+1.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +757.4% | -16.1% | -13.7% | +293.1% | -21.8% | +17.7% | -5.9% | -19.3% | -3.6% | +0.4% | -4.2% | +245.2% | +41.5% | +72.4% | +1.2% | -3.2% | +33.3% | +56.4% | +28.1% | -13.9% | -4.9% | +4.9% | -0.7% | +7.4% | |
| – | – | – | – | +320.9% | -26.3% | +10.3% | -22.9% | +20.1% | -2.2% | +1.8% | -8.5% | +83.9% | +78.2% | -20.1% | +14.7% | -4.0% | +112.3% | -18.0% | +114.3% | -36.1% | +9.8% | +23.7% | +0.6% | +20.4% | |
| – | – | – | -50.2% | +430.1% | -45.7% | -12.7% | -11.9% | -22.2% | -52.5% | +130.7% | -20.6% | +92.1% | +90.6% | -16.3% | +1.9% | -9.9% | +47.8% | -11.6% | +47.3% | +4.1% | +33.1% | +45.1% | +45.6% | +36.4% | |
| – | – | – | – | +553.2% | -42.3% | +2.7% | -42.8% | +37.3% | -20.0% | +12.8% | -15.4% | +118.4% | +127.6% | -42.0% | +27.3% | -21.7% | +261.1% | -34.2% | +198.6% | -51.2% | +1.7% | +13.4% | -10.6% | +36.4% | |
| – | – | – | – | +38.2% | +34.9% | +9.6% | -9.4% | +11.3% | +30.8% | +0.4% | +4.6% | +37.2% | +28.6% | +10.5% | +8.7% | +9.4% | +9.1% | +11.3% | -17.5% | +42.7% | +29.3% | +23.0% | +14.9% | +10.5% | |
| – | – | – | +70.2% | +96.4% | +58.7% | +55.4% | +20.8% | -23.4% | +16.6% | +15.5% | -12.9% | +78.6% | +39.6% | +23.9% | +0.0% | +27.1% | +0.1% | +30.8% | +19.1% | +11.2% | +17.9% | +47.8% | +11.0% | +4.2% | |
| – | – | – | +28.5% | +39.4% | +8.5% | +22.6% | -17.5% | -18.3% | -9.5% | -13.7% | +45.9% | +64.5% | +104.7% | +170.8% | -4.1% | -4.2% | -5.8% | +20.6% | -13.3% | +27.9% | +17.8% | – | – | – | |
| – | – | – | – | – | -20.4% | +76.1% | +0.7% | -95.8% | -68.9% | -49.9% | -28.6% | +110,481.3% | +0.0% | +197.5% | +0.0% | +0.0% | +0.0% | +123.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | -84.0% | +10.1% | -33.1% | -49.5% | -68.9% | -49.9% | -28.6% | +32,084.4% | -13.8% | +505.7% | -3.1% | -2.6% | -3.0% | +163.7% | -1.3% | -66.5% | -8.5% | +62.7% | -11.8% | -14.9% | |
| – | +76.9% | +5,853.4% | +18.9% | -82.9% | +23.0% | +16.6% | +44.9% | +25.6% | -5.1% | +7.4% | +9.2% | +97.4% | -34.3% | +234.1% | +25.0% | -1.3% | +0.8% | +189.2% | -2.7% | -56.5% | -2.2% | +14.8% | +0.4% | +9.4% | |
| – | – | – | +271.0% | +74.6% | +32.6% | +20.7% | -12.3% | +45.6% | +10.4% | -17.1% | +12.9% | +118.9% | -4.0% | +23.2% | -8.7% | +10.7% | +26.1% | +24.1% | -1.6% | +14.9% | +3.4% | +27.7% | -1.5% | +11.0% | |
| – | – | – | – | – | +5.8% | +110.8% | -95.9% | +6,450.5% | -1.5% | -29.7% | +31.5% | +0.4% | +95.3% | -88.7% | +275.1% | -66.8% | +740.8% | -53.0% | +279.5% | -79.1% | +211.6% | -53.7% | +10.7% | +11.3% | |
| – | – | – | +162.9% | +69.5% | +55.2% | +141.0% | +10.7% | -30.1% | +25.3% | +16.8% | -3.2% | +68.6% | -11.4% | +67.2% | -16.3% | +16.5% | -22.3% | +54.8% | -14.8% | +46.0% | +7.0% | +37.5% | -8.5% | +213.2% | |
| – | – | – | – | – | -36.1% | -59.2% | +2,033.2% | -55.8% | -75.2% | +644.1% | +30.1% | -31.1% | -98.3% | +18,427.0% | +74.2% | +0.9% | +47.6% | +67.6% | -10.4% | +11.8% | -4.9% | +6.6% | +2.1% | +0.0% | |
| – | +883.2% | -211.3% | – | – | -28.9% | +18.1% | -19.6% | -41.3% | -2.1% | -6.7% | -19.9% | +480.8% | +82.5% | +40.9% | -9.8% | -4.3% | +54.7% | -0.8% | +66.7% | +17.3% | -5.6% | +2.1% | -1.1% | +6.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.6% | +0.8% | +2.0% | +229.5% | +101.4% | +10.3% | +6.0% | +2.6% | +3.6% | +3.8% | +3.3% | +26.2% | +29.1% | +6.4% | +12.7% | +2.5% | +5.2% | +10.3% | +12.1% | +9.3% | -0.6% | +1.2% | +1.4% | +1.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.